Becton Dickinson & Co. Deposit Repr 1/20th Cum Conv Pfd Registered Series A

Becton, Dickinson & Co. engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Becton, Dickinson and Co.

The test is based on the company's BD Veritor Plus System, a handheld diagnostic device.

FDA Approves Becton Dickinson Portable 15-Minute Coronavirus Test

Becton Dickinson gained U.S. authorization for its third coronavirus test on Monday, sending BDX stock flying in early action.

Covid Report: Medical Giant Surges On Its 15-Minute Coronavirus Test

Becton Dickinson (NYSE: BDX) said on Monday that it received emergency use authorisation (EUA) from the U.S. Food and Drug Administration (FDA) for its COVID-19 antigen test that takes up to 15 minutes to produce results.

Beckton Dickinson receives EUA for its COVID-19 antigen test from the U.S. FDA

Shares of Becton Dickinson & Co. BDX, +1.44% gained 3.6% in premarket trading on Monday after the diagnostics company announced the launch of a point-of-care COVID-19 antigen test that can detect the coronavirus in 15 minutes.

BD's stock gains on launch of rapid COVID-19 diagnostic test

The U.S. Food and Drug Administration has granted emergency use authorization (EUA) to Becton Dickinson for a Covid-19 antigen test that can be administered at the point of care and produce results within 15 minutes, the company said on Monday.

U.S. regulator greenlights Becton Dickinson's rapid antigen test for coronavirus

Becton Dickinson: COVID-19, A Potential Revenue Driver

Becton Dickinson (BDX) reported earnings 30 days ago. What's next for the stock?

Why Is Becton Dickinson (BDX) Down 5.6% Since Last Earnings Report?

American Electric Power Company

Costco

Southwest Airlines

Peloton

With the market finding its way through tricky economic territory, investors will have to strike a careful balance between offensive and defensive moves.

5 Stocks to Buy for an Uncertain 2020

Boston Scientific

Omega Healthcare Investors

REGENXBIO

With the COVID-19 pandemic being the biggest health care story in years, it is no surprise that investors and traders have been closely watching and have been doing analysis on the top companies in the S&P health care sector, which returned a solid 3.1% in May.

Raymond James Makes Huge June Changes to Top Picks Health Care List

Becton Dickinson and Co (NYSE: BDX) shares are trading lower on Wednesday. The company announced an offering of $1.5 billion of common stock and $1.5 billion of Depositary shares representing interests in mandatory convertible preferred stock.

Why Becton Dickinson's Stock Is Trading Lower Today

Despite legal troubles with investors, Becton Dickinson has shown remarkable agility for its size with its COVID-19 testing program.

Is Becton Dickinson’s Investor Lawsuit Creating A Great Buying Opportunity?

Becton Dickinson & Co. BDX, +0.01% disclosed Wednesday it was offering the sale of $1.5 billion in 10-year and 30-year notes, as the medical technology company looks to repay $1 billion in debt due this year.

Becton Dickinson to issue $1.5 billion in 10-year, 30-year notes to payoff lower-rate debt due this year

Becton Dickinson and Company's (BDX) CEO Tom Polen on Q2 2020 Results - Earnings Call Transcript

Becton Dickinson's (BDX) second-quarter results reflect solid performance by the core Life Sciences and Interventional segments.

Becton Dickinson (BDX) Q2 Earnings and Revenues Top Estimates

Becton, Dickinson's (BDX) fiscal second-quarter results likely to reflect robust performance at BD Life Sciences. However, forex is likely to have remained a woe.

What's in Store for Becton, Dickinson's (BDX) Q2 Earnings?

Becton Dickinson, a maker of medical gear including coronavirus tests, is near a possible buy zone ahead of its next quarterly earnings report, slated for early May 7.
The post Top-Rated Becton Dickinson Near Buy Point After 2nd FDA Coronavirus Test Nod appeared first on Investor's Business Daily.

Top-Rated Becton Dickinson Near Buy Point After 2nd FDA Coronavirus Test Nod

Church & Dwight

Johnson & Johnson

Ventas

Walmart

The CARES Act will be great for healthcare and consumer stocks alike. These five stocks to buy could be the biggest winners.

5 Stocks to Buy For Big Gains On CARES Act Stimulus

Abbott Labs

Hologic

Henry Schein

iShares U.S. Medical Devices ETF

iShares U.S. Healthcare ETF

QIAGEN

Thermo Fisher Scientific

Vanguard Health Care ETF

Health Care Select Sector SPDR Fund

It seems that testing for COVID-19 is the major key in controlling the outbreak and helps in making decisions like treatment protocols,  resource allocation and drafting the right healthcare policies.

Healthcare Stocks & ETFs to Gain on Coronavirus Test Progress

Colgate-Palmolive

Clorox

Hormel Foods

In our search for the five safest dividend stocks around, we’ve looks for investments with a unique mix of characteristics, including being S&P 500 Dividend Aristocrats with 25+ years of consecutive dividend increases, notes income expert Ben Reynolds, a contributor to MoneyShow.com.

The 5 Safest Dividend Stocks In The S&P 500

Becton Dickinson and BioMedomics are the latest companies to launch a quick point-of-care SARS-CoV-2 diagnostic.

There's a New 15-Minute Coronavirus Test

Becton, Dickinson and Co. (NYSE: BDX), or BD, is officially throwing its hat in the ring to fight COVID-19.

What Becton Dickinson Brings to the Fight Against COVID-19

BD (BDX), along with BioMedomics, launches a new point-of-care test to help fight the coronavirus outbreak.

BD Launches New Test to Help Combat the Coronavirus Outbreak

AbbVie

Automatic Data Processing

Aflac

A. O. Smith

Cardinal Health

Chubb

Dover

Ecolab

Emerson Electric

General Dynamics

Genuine Parts

McDonald's

Medtronic

McCormick

Nucor

Walgreens

In times of market turmoil, one group of stocks that investors can count on to deliver reliable income growth is the Dividend Aristocrats: an elite group of companies that have produced at least 25 consecutive years of dividend hikes.

19 Dividend Aristocrats That Have Gone on Deep Discount

Diagnostics giant Becton Dickinson said has submitted an emergency request to the U. S. Food and Drug Administration to increase capacity of tests for the has teamed with molecular diagnostics company BioGX and submitted "Emergency Use Authorization" requests to the Food and Drug Administration f.

Becton Dickinson Seeks Emergency FDA Request To Ramp Up Coronavirus Tests

Anthem

AutoZone

Hershey

Humana

LogMeIn

Mettler-Toledo

O'Reilly Automotive

UnitedHealth Group

Top Stocks To Own As Coronavirus Epidemic Shocks US Stocks.  A Coronavirus Portfolio to help you invest in the current market tumult.

News for Becton Dickinson & Co. Deposit Repr 1/20th Cum Conv Pfd Registered Series A Stock (BDXA)